KMTSKestra Medical Technologies, Ltd.
$26.95+8.0% 1Y
$26.95
$17.8752 weeks$28.44
KMTS in its own filings
Nothing in KMTS's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
32
Events found in the filings · across 175 filings · the record starts in 2021
- Hard flags
- none
Hard flags
- Most recent filing
- Sep 14, 2026
Most recent filing · Form 10-Q
- Record starts
- Sep 29, 2021
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Dec 10, 2026
- SEC comment-letter activity9 occurrences
- 2025-12-01
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 14, 2026Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results.Earnings release · press release
- Jul 14, 2026On July 10, 2026, Kestra Medical Technologies, Ltd. (the “Company”), its wholly-owned subsidiary, Kestra Medical Technologies, Inc. (the “Borrower”) and other credit parties thereto (collectively with the Borrower and the Company, the “Credit Parties”), entered into a loan agreement (the “Loan Agreement”) with BPCR …Material agreement entered · Form 8-K
- Mar 17, 2026Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results.Earnings release · press release
- Dec 11, 2025Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results.Earnings release · press release
- Dec 4, 2025On December 2, 2025, Kestra Medical Technologies, Ltd., a Bermuda exempted company (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several …Material agreement entered · Form 8-K
- Dec 1, 2025Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results.Earnings release · press release
- Nov 10, 2025Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s ASSURE Device.Regulation FD disclosure · press release
- Sep 11, 2025Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Medical Instruments & Supplies
The closest names by size in the same industry